Latest News

  A single dose of the Sputnik V vaccine may be enough to elicit strong antibody response against SARS-CoV-2, the virus that causes COVID-19, in already infected people, according to a study. Previous studies have found that two doses of Sputnik V, a vector vaccine produced using a combination of two adenoviruses, results in 92 per cent efficacy against COVID-19 infection. Adenoviruses are common viruses that cause a range of illness with cold-like symptoms such as fever and sore throat. The new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly. Click Here

  As artificial intelligence (Ai) technology gets all-pervasive, the European Union is considering a ban on the use of AI for mass surveillance and social credit scores, among other applications. The leaked draft proposal, first reported by Politico and is expected to be made official next week, would see the EU take a strong stance on certain applications of AI, similar to the EU's regulation of digital privacy under the GDPR (General Data Protection Regulation), reports The Verge. According to the draft, a ban on AI is needed for "indiscriminate surveillance," including systems that directly track individuals in physical environments or aggregate data from other sources. It also seeks a ban on AI systems that create social credit scores, which means judging someone's trustworthiness based on social behavior or predicted personality traits. Read More